Research programme: infertility therapeutics - Merck Sharp and Dohme

Drug Profile

Research programme: infertility therapeutics - Merck Sharp and Dohme

Alternative Names: ORG 214444; ORG 241549; ORG 33409

Latest Information Update: 23 Feb 2015

Price : $50

At a glance

  • Originator Organon
  • Developer Merck & Co
  • Class Dihydropyridines; Follicle stimulating hormones; Gonadotropins; Recombinant proteins
  • Mechanism of Action Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Female infertility

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top